Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?

Lung

Volumn 191, Issue 1, 2013, Pages 43-52

  Marcellis, Rik G J ^a   Lenssen, Antoine F ^a   De Vries, Geeuwke J ^b   Baughman, Robert P ^c   Van Der Grinten, Chris P ^a   Verschakelen, Johny A ^d   De Vries, Jolanda ^e   Drent, Marjolein ^f  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ORBIS MC ^*  (Netherlands)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e TILBURG UNIVERSITY   (Netherlands)

^f GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

Cardiopulmonary exercise testing; DLCO; Lung function; Muscle strength; Pulmonary gas exchange impairment; Sarcoidosis

Indexed keywords

C REACTIVE PROTEIN; CARBON MONOXIDE; PREDNISONE; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BICYCLE ERGOMETER; BLOOD GAS ANALYSIS; BODY COMPOSITION; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CLINICAL FEATURE; DISEASE SEVERITY; DYSPNEA; ERGOMETER; EXERCISE; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL DISEASE; HEART RATE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPIROMETRY; THORAX RADIOGRAPHY;

ADULT; BIOLOGICAL MARKERS; BREATH TESTS; CARBON MONOXIDE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PULMONARY DIFFUSING CAPACITY; PULMONARY GAS EXCHANGE; REST; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY;

EID: 84873089441     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-012-9432-6     Document Type: Article

References (48)

1. No authors listed (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2):736-755
2. Baughman RP, Culver DA, Judson MA (2011) A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 183(5):573-581
3. Baughman RP, Nunes H (2012) Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol 8(1):95-103
4. Morgenthau AS, Iannuzzi MC (2011) Recent advances in sarcoidosis. Chest 139(1):174-182
5. Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357(21):2153-2165
6. Wirnsberger RM, de Vries J, Wouters EF, Drent M (1998) Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. Neth J Med 53(2):53-60
7. Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J (2006) Fatigue is associated with quality of life in sarcoidosis patients. Chest 130(4):989-994
8. Elfferich MD, Nelemans PJ, Ponds RW, De Vries J, Wijnen PA, Drent M (2010) Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 80:212-219
9. Korenromp IH, Heijnen CJ, Vogels OJ, van den Bosch JM, Grutters JC (2011) Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest 140(2):441-447
10. Baydur A, Alavy B, Nawathe A, Liu S, Louie S, Sharma OP (2011) Fatigue and plasma cytokine concentrations at rest and during exercise in patients with sarcoidosis. Clin Respir J 5(3):156-164
11. Drent M, Lower EE, De Vries J (2012) Sarcoidosis-associated fatigue. Eur Respir J 40(1):255-263
12. Mostard RL, Voo S, van Kroonenburgh MJ, Verschakelen JA, Wijnen PA, Nelemans PJ, Erckens RJ, Drent M (2011) Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 105(12):1917-1924
13. Lopes AJ, de Menezes SL, Dias CM, de Oliveira JF, Mainenti MR, Guimaraes FS (2011) Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis. Lung 189(5):425-431
14. Gafa G, Sverzellati N, Bonati E et al (2012) Follow-up in pulmonary sarcoidosis: comparison between HRCT and pulmonary function tests. Radiol Med 117(6):968-978
15. Erdal BS, Crouser ED, Yildiz V, King MA, Patterson AT, Knopp MV, Clymer BD (2012) Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis. Chest doi: 10.1378/chest.11-2027
16. Nunes H, Uzunhan Y, Gille T, Lamberto C, Valeyre D, Brillet PY (2012) Imaging of sarcoidosis of the airways and lung parenchyma with correlation with lung function. Eur Respir J 40(3):750-765
17. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS (1995) Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 107(2):323-329
18. Barros WG, Neder JA, Pereira CA, Nery LE (2004) Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis. Respiration 71(4):367-373
19. Athos L, Mohler JG, Sharma OP (1986) Exercise testing in the physiologic assessment of sarcoidosis. Ann N Y Acad Sci 465:491-501
20. Karetzky M, McDonough M (1996) Exercise and resting pulmonary function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 13(1):43-49
21. Baughman RP, Lower EE (2007) Six-minute walk test in managing and monitoring sarcoidosis patients. Curr Opin Pulm Med 13(5):439-444
22. Marcellis RG, Lenssen AF, Elfferich MD, De Vries J, Kassim S, Foerster K, Drent M (2011) Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J 38(3):628-634
23. Medinger AE, Khouri S, Rohatgi PK (2001) Sarcoidosis: the value of exercise testing. Chest 120(1):93-101
24. Risk C, Epler GR, Gaensler EA (1984) Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest 85(1):69-74
25. Bradvik I, Wollmer P, Blom-Bulow B, Albrechtsson U, Jonson B (1991) Lung mechanics and gas exchange during exercise in pulmonary sarcoidosis. Chest 99(3):572-578
26. Lopes AJ, Menezes SL, Dias CM, Oliveira JF, Mainenti MR, Guimaraes FS (2012) Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis. Braz J Med Biol Res 45(3):256-263
27. Bourbonnais JM, Samavati L (2008) Clinical predictors of pulmonary hypertension in sarcoidosis. Eur Respir J 32(2):296-302
28. Corte TJ, Wells AU, Nicholson AG, Hansell DM, Wort SJ (2011) Pulmonary hypertension in sarcoidosis: a review. Respirology 16(1):69-77
29. Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16(2):149-173
30. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16:5-40
31. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG, Drent M (2003) Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 49(9):1510-1517
32. American College of Chest Physicians, American Thoracic Society (2003) ATS/ACCP Statement on cardiopulmonary exercise testing. Joint Statement of the American Thoracic Society (ATS) and the American College of Chest Physicians (ACCP) was adopted by the ATS Board of Directors and by the ACCP Health Science Policy Committee, November 1, 2001. Am J Respir Crit Care Med 167(2):211-277
33. Warrell DA, Cox TM, Firth JD, Benz EJ (2005) Oxford textbook of medicine, 4th edn. Oxford University Press, New York
34. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ (2005) Principles of exercise testing and interpretation, 4th edn. Lippincott Williams & Wilkins, Philadelphia
35. Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99:696-702
36. Harik-Khan RI, Wise RA, Fozard JL (1998) Determinants of maximal inspiratory pressure. The baltimore longitudinal study of aging. Am J Respir Crit Care Med 158(5 Pt 1):1459-1464
37. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S (1985) Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 66(2):69-74
38. Michielsen HJ, De Vries J, Van Heck GL, Van de Vijver FJR, Sijtsma K (2004) Examination of the dimensionality of fatigue: the construction of the fatigue assessment scale (FAS). Eur J Psychol Assess 20(1):39-48
39. Baydur A (2012) Recent developments in the physiological assessment of sarcoidosis: clinical implications. Curr Opin Pulm Med 18(5):499-505
40. Spruit MA, Thomeer MJ, Gosselink R, Troosters T, Kasran A, Debrock AJ, Demedts MG, Decramer M (2005) Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 60(1):32-38
41. Wirnsberger RM, Drent M, Hekelaar N, Breteler MH, Drent S, Wouters EF, Dekhuijzen PN (1997) Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 10(7):1450-1455
42. Wallaert B, Talleu C, Wemeau-Stervinou L, Duhamel A, Robin S, Aguilaniu B (2011) Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity. Respiration 82(6):501-508
43. Sietsema KE, Kraft M, Ginzton L, Sharma OP (1992) Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 102(3):838-845
44. De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, Drent M (2004) The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21(2):127-136
45. Ingram CG, Reid PC, Johnston RN (1982) Exercise testing in pulmonary sarcoidosis. Thorax 37(2):129-132
46. Arena R, Sietsema KE (2011) Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 123(6):668-680
47. Kollert F, Geck B, Suchy R et al (2011) The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med 105(1):122-129
48. Palmero V, Sulica R (2010) Sarcoidosis-associated pulmonary hypertension: assessment and management. Semin Respir Crit Care Med 31(4):494-500